BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10794688)

  • 1. New proline mimetics: synthesis of thrombin inhibitors incorporating cyclopentane- and cyclopentenedicarboxylic acid templates in the P2 position. Binding conformation investigated by X-ray crystallography.
    Nöteberg D; Brånalt J; Kvarnström I; Linschoten M; Musil D; Nyström JE; Zuccarello G; Samuelsson B
    J Med Chem; 2000 May; 43(9):1705-13. PubMed ID: 10794688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of potential thrombin inhibitors. Incorporation of tartaric acid templates as P2 proline mimetics.
    Dahlgren A; Brånalt J; Kvarnström I; Nilsson I; Musil D; Samuelsson B
    Bioorg Med Chem; 2002 May; 10(5):1567-80. PubMed ID: 11886818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of thrombin inhibitors incorporating a novel 4-amino-morpholinone sscaffold: analysis of X-ray crystal structure of enzyme inhibitor complex.
    Nilsson JW; Kvarnström I; Musil D; Nilsson I; Samulesson B
    J Med Chem; 2003 Sep; 46(19):3985-4001. PubMed ID: 12954052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel thrombin inhibitors. Use of ring-closing metathesis reactions for synthesis of P2 cyclopentene- and cyclohexenedicarboxylic acid derivatives.
    Thorstensson F; Kvarnström I; Musil D; Nilsson I; Samuelsson B
    J Med Chem; 2003 Mar; 46(7):1165-79. PubMed ID: 12646027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel morpholinone-based D-Phe-Pro-Arg mimics as potential thrombin inhibitors: design, synthesis, and X-ray crystal structure of an enzyme inhibitor complex.
    Dahlgren A; Johansson PO; Kvarnström I; Musil D; Nilsson I; Samuelsson B
    Bioorg Med Chem; 2002 Jun; 10(6):1829-39. PubMed ID: 11937341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.
    Wang G; Goyal N; Hopkinson B
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3798-803. PubMed ID: 19447619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides and pseudopeptides incorporating D-Phe-Pro-Arg and Arg-Gly-Asp lead sequences as potential antithrombotic agents.
    Ilas J; Hudecz F; Süli-Vargha H; Kikelj D
    J Pept Sci; 2008 Aug; 14(8):946-53. PubMed ID: 18383437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.
    Bäck M; Johansson PO; Wångsell F; Thorstensson F; Kvarnström I; Ayesa S; Wähling H; Pelcman M; Jansson K; Lindström S; Wallberg H; Classon B; Rydergård C; Vrang L; Hamelink E; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2007 Nov; 15(22):7184-202. PubMed ID: 17845856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenolic P2/P3 core motif as thrombin inhibitors--design, synthesis, and X-ray co-crystal structure.
    Hanessian S; Therrien E; van Otterlo WA; Bayrakdarian M; Nilsson I; Fjellström O; Xue Y
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1032-6. PubMed ID: 16290930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of direct thrombin inhibitors bearing 4-(piperidin-1-yl)pyridine at the P1 position with potent anticoagulant activity.
    de Candia M; Fiorella F; Lopopolo G; Carotti A; Romano MR; Lograno MD; Martel S; Carrupt PA; Belviso BD; Caliandro R; Altomare C
    J Med Chem; 2013 Nov; 56(21):8696-711. PubMed ID: 24102612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
    Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.
    Isaacs RC; Solinsky MG; Cutrona KJ; Newton CL; Naylor-Olsen AM; McMasters DR; Krueger JA; Lewis SD; Lucas BJ; Kuo LC; Yan Y; Lynch JJ; Lyle EA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2062-6. PubMed ID: 18291642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active site-directed thrombin inhibitors: alpha-hydroxyacyl-prolyl-arginals. New orally active stable analogs of D-Phe-Pro-Arg-H.
    Bajusz S; Barabás E; Fauszt I; Fehér A; Horváth G; Juhász A; Szabó AG; Széll E
    Bioorg Med Chem; 1995 Aug; 3(8):1079-89. PubMed ID: 7582981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of a small library of graftable thrombin inhibitors derived from (L)-arginine.
    Salvagnini C; Gharbi S; Boxus T; Marchand-Brynaert J
    Eur J Med Chem; 2007 Jan; 42(1):37-53. PubMed ID: 17010480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of potent bivalent thrombin inhibitors based on hirudin sequence: incorporation of nonsubstrate-type active site inhibitors.
    Tsuda Y; Cygler M; Gibbs BF; Pedyczak A; Féthière J; Yue SY; Konishi Y
    Biochemistry; 1994 Dec; 33(48):14443-51. PubMed ID: 7981204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel non-covalent thrombin inhibitors incorporating P(1) 4,5,6,7-tetrahydrobenzothiazole arginine side chain mimetics.
    Marinko P; Krbavcic A; Mlinsek G; Solmajer T; Bakija AT; Stegnar M; Stojan J; Kikelj D
    Eur J Med Chem; 2004 Mar; 39(3):257-65. PubMed ID: 15051174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acids and peptides. XVI. Synthesis of N-terminal tetrapeptide analogs of fibrin alpha-chain and their inhibitory effects on fibrinogen/thrombin clotting.
    Kawasaki K; Hirase K; Miyano M; Tsuji T; Iwamoto M
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3253-60. PubMed ID: 1294328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Evaluation of Spumigin Analogues Library with Thrombin Inhibitory Activity.
    Žula A; Będziak I; Kikelj D; Ilaš J
    Mar Drugs; 2018 Oct; 16(11):. PubMed ID: 30373260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.